quinoxalines has been researched along with Acquired Immune Deficiency Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlotti, A; Douguet, L; Dupin, N; Dwyer, J; Galan Moya, EM; Gavard, J; Grange, PA; Gutkind, JS; Le Guelte, A; Sumbal, M | 1 |
| Bender, R; Billhardt, UM; Kleim, JP; Meichsner, C; Paessens, A; Riess, G; Rösner, M; Winkler, I | 1 |
| Huguenel, E; Kleim, JP; Paessens, A; Rübsamen-Waigmann, H; Shah, A; Wainberg, MA | 1 |
2 trial(s) available for quinoxalines and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Second-generation non-nucleosidic reverse transcriptase inhibitor HBY097 and HIV-1 viral load.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiviral Agents; Cohort Studies; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Mutation; Placebos; Quinoxalines; Reverse Transcriptase Inhibitors; Viral Load; Viremia; Virus Replication | 1997 |
Los Angeles, New York, Stanford University: HBY 097, new drug may weaken HIV.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; HIV; HIV Reverse Transcriptase; Humans; Los Angeles; Mutation; New York; Quinoxalines; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; San Francisco | 1995 |
3 other study(ies) available for quinoxalines and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Remodeling of VE-cadherin junctions by the human herpes virus 8 G-protein coupled receptor.
Topics: Acquired Immunodeficiency Syndrome; Androstadienes; Animals; Antigens, CD; Cadherins; Capillary Permeability; Cell Line; Chromones; Cinnamates; Endothelial Cells; Enzyme Inhibitors; Female; Furans; Herpesvirus 8, Human; Humans; Indoles; Intercellular Junctions; Mice; Mice, Nude; Morpholines; Phosphatidylinositol 3-Kinases; Pyridines; Pyrimidines; Quinoxalines; Receptors, Chemokine; RNA, Small Interfering; Sarcoma, Kaposi; Skin; Skin Neoplasms; Sulfonamides; Thiazolidinediones; Wortmannin | 2011 |
[New substance against AIDS in clinical trial].
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials, Phase I as Topic; HIV Reverse Transcriptase; Humans; Quinoxalines; Reverse Transcriptase Inhibitors | 1995 |
Activity of a novel quinoxaline derivative against human immunodeficiency virus type 1 reverse transcriptase and viral replication.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Base Sequence; Cells, Cultured; Female; HIV Reverse Transcriptase; Lymphocytes; Mice; Mice, Inbred Strains; Molecular Sequence Data; Mutagenesis, Site-Directed; Quinoxalines; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Virus Replication | 1993 |